A single-center, retrospective, observational study of alemtuzumab in renal retransplantation: Transplant outcomes and associated infections
Latest Information Update: 22 Nov 2021
At a glance
- Drugs Alemtuzumab (Primary) ; Antithymocyte globulin; Basiliximab; Ciclosporin; Methylprednisolone; Mycophenolate mofetil; Mycophenolic acid; Tacrolimus
- Indications Chronic lymphocytic leukaemia; Multiple sclerosis; Precursor cell lymphoblastic leukaemia-lymphoma; T-cell prolymphocytic leukaemia
- Focus Adverse reactions
- 22 Nov 2021 New trial record
- 10 Nov 2021 Results published in the Transplantation Proceedings.